Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)

6.08
BATS BZX Real-Time Price
As of 12:41pm ET
 -0.07 / -1.14%
Today’s Change
3.57
Today|||52-Week Range
9.93
+50.87%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$316.2M

Company Description

Tetraphase Pharmaceuticals, Inc. engages in the development and production of novel antibiotics for serious and life-threatening bacterial infections. It is currently developing a product candidate, eravacycline, a fully synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Watertown, MA.

Contact Information

Tetraphase Pharmaceuticals, Inc.
480 Arsenal Street
Watertown Massachusetts 02472
P:(617) 715-3600
Investor Relations:
(617) 600-7040

Employees

Shareholders

Other institutional32.88%
Mutual fund holders27.52%
Individual stakeholders22.36%

Top Executives

Guy MacDonaldPresident, Chief Executive Officer & Director
Kamalam UnninayarChief Financial Officer
Patrick Taylor HornChief Medical Officer
Jacques DumasChief Scientific Officer
Maria D. StahlSenior Vice President & General Counsel